Welcome to LookChem.com Sign In|Join Free
  • or
2,5-difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1269233-00-2

Post Buying Request

1269233-00-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1269233-00-2 Usage

Chemical compound

2,5-difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Member of the aniline family
Contains two fluorine atoms and a boron-containing group attached to the aniline ring
Utilized as a building block in the synthesis of various organic compounds and materials
Used in pharmaceutical and agricultural industries
Studied for potential use in medical research and development
Must be handled with care and according to safety guidelines due to potential health hazards if mishandled.

Check Digit Verification of cas no

The CAS Registry Mumber 1269233-00-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,9,2,3 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1269233-00:
(9*1)+(8*2)+(7*6)+(6*9)+(5*2)+(4*3)+(3*3)+(2*0)+(1*0)=152
152 % 10 = 2
So 1269233-00-2 is a valid CAS Registry Number.

1269233-00-2Downstream Products

1269233-00-2Relevant academic research and scientific papers

Compounds and Compositions as Protein Kinase Inhibitors

-

, (2011/04/14)

The present invention provides compounds of Formula I or II: wherein R1, R1b, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds of Formula (I) or (II) and pharmaceutical compositions thereof are useful for the treatment of B-Raf-associated diseases.

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

-

Page/Page column 53, (2011/04/14)

The invention provides a novel class of compounds of formula 1, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1269233-00-2